Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/21/2012DE102011006610B3 Aptamere, die spezifisch sind für Immunoglobulin bindende Zellwandproteine Aptamers that are specific for immunoglobulin binding cell wall proteins
06/21/2012DE102010063612A1 Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3-yl]-carbamidsäureethylester und 2-[2-[(2,6-Dichlorphenyl)-amino]-phenyl]-essigsäure New multi-component crystals of ([2-amino-6- (4-fluoro-benzylamino) -pyridin-3-yl] -carbamic acid ethyl ester and 2- [2 - [(2,6-dichlorophenyl) -amino] -phenyl] -acetic acid
06/21/2012DE102010063609A1 Neue Multikomponentenkristalle aus ([2-Amino-6-(4-fluoro-benzylamino)-pyridin-3yl)-carbamidsäureethylester und einer Arylpropionsäure New multi-component crystals of ([2-amino-6- (4-fluoro-benzylamino) -pyridin-3-yl) -carbamic acid ethyl ester and a arylpropionic
06/21/2012DE102010063127A1 Flüssige, oral applizierbare pharmazeutische Zusammensetzungen enthaltend Liquid, orally administrable pharmaceutical compositions containing 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
06/21/2012DE102010055566A1 New compounds conjugating gyrase-inhibiting substances with catechol structural units, are gyrase inhibitors, useful as biologically active substances, and for treating bacterial infection
06/21/2012DE102010055322A1 Antibakteriell und antimykotisch wirkende Substanzen Antibacterial and antifungal substances acting
06/21/2012CA2856984A1 Reproductive cell maintenance system
06/21/2012CA2822071A1 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
06/21/2012CA2822062A1 Inhibitors of influenza viruses replication
06/21/2012CA2822059A1 Inhibitors of influenza viruses replication
06/21/2012CA2822057A1 Inhibitors of influenza viruses replication
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012CA2822040A1 Phosphorous derivatives as chemokine receptor modulators
06/21/2012CA2822039A1 Sulfur derivatives as chemokine receptor modulators
06/21/2012CA2822003A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012CA2822002A1 Azaindoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822001A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822000A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012CA2821999A1 Benzimidazole respiratory syncytial virus inhibitors
06/21/2012CA2821984A1 Thiosemicarbazone compounds and use in the treatment of cancer
06/21/2012CA2821975A1 Novel n-(4-(azetidine - 1 - carbonyl)phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
06/21/2012CA2821973A1 Anti-viral compounds
06/21/2012CA2821972A1 Bicyclic triazole and pyrazole lactams as allosteric modulators of mglur5 receptors
06/21/2012CA2821967A1 Steroid tetrol solid state forms-2
06/21/2012CA2821952A1 Melanoma treatments
06/21/2012CA2821900A1 Continuous arycyclic compound
06/21/2012CA2821893A1 Pyrazole derivative
06/21/2012CA2821837A1 2-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821834A1 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821829A1 Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821827A1 6-thio-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821819A1 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821817A1 Substituted 6-imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders
06/21/2012CA2821805A1 Controlled release oral dosage forms of poorly soluble drugs and uses thereof
06/21/2012CA2821777A1 Substituted pyrimido[1,2-b]indazoles and their use as modulators of the pi3k/akt pathway
06/21/2012CA2821712A1 Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as type iii receptor tyrosine kinase inhibitors
06/21/2012CA2821667A1 Composition usable in the treatment of cellular degeneration
06/21/2012CA2821613A1 Preparation comprising insulin, nicotinamide and an amino acid
06/21/2012CA2821598A1 Use of glycosaminoglycan lipoate esters in the trichology field
06/21/2012CA2821223A1 Novel therapeutic strategies for improving an anticancer treatment
06/21/2012CA2821196A1 Gastric and colonic formulations and methods for making and using them
06/21/2012CA2821138A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012CA2821102A1 Crystalline forms of 5-chloro-n2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-n4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine
06/21/2012CA2821080A1 Universal anti-tag chimeric antigen receptor-expressing t cells and methods of treating cancer
06/21/2012CA2821032A1 A composition comprising an antibiotic and a dispersant or an anti -adhesive agent
06/21/2012CA2820871A1 Disease inhibiting agent
06/21/2012CA2820625A1 3-methanesulfonylpropionitrile for treating inflammation and pain
06/21/2012CA2820440A1 The abcg1 gene as a marker and a target gene for treating obesity
06/21/2012CA2820078A1 Tricyclic pi3k inhibitor compounds and methods of use
06/21/2012CA2819970A1 Novel benzofurane compounds
06/21/2012CA2819894A1 Anti-viral compounds
06/21/2012CA2819620A1 Modulators of histone methyltransferase, and methods of use thereof
06/21/2012CA2819515A1 Cyp11b, cyp17, and/or cyp21 inhibitors
06/21/2012CA2819426A1 Combination therapy comprising vemurafenib and an interferon for use in the treatment of cancer
06/21/2012CA2819317A1 Compounds useful for treating aids
06/21/2012CA2819171A1 New compounds for the treatment of neurodegenerative diseases
06/21/2012CA2819108A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration
06/21/2012CA2818903A1 Casein kinase 1delta (ck1delta) inhibitors
06/21/2012CA2818627A1 Oxime compounds as hdl-cholesterol raising agents
06/21/2012CA2817461A1 Transdermal therapeutic system for administering an active substance
06/21/2012CA2817460A1 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
06/21/2012CA2816042A1 Peptide-based in vivo sirna delivery system
06/21/2012CA2814953A1 Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules
06/21/2012CA2812223A1 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
06/20/2012EP2465938A1 Production method for astaxanthin-containing composition
06/20/2012EP2465937A1 Methods for the production of 3-o-deactivated-4'-monophosphoryl lipid A (3D-MLA)
06/20/2012EP2465928A1 Treatment of Th17-mediated diseases
06/20/2012EP2465859A1 8-Triazolylxanthine derivatives, processes for their production and their use as adenosine receptor antagonists
06/20/2012EP2465857A1 Methods for synthesizing heterocyclic compounds
06/20/2012EP2465856A2 Cytochrome P450 oxidase inhibitors and uses thereof
06/20/2012EP2465855A1 Cytochrome P450 oxidase inhibitors and uses thereof
06/20/2012EP2465853A1 Polymorph of rufinamide and process for obtaining it
06/20/2012EP2465852A1 Capped pyrazinoylguanidine sodium channel blockers
06/20/2012EP2465851A1 1-Aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof
06/20/2012EP2465850A1 Therapeutic compounds
06/20/2012EP2465847A1 Azetidinone compounds and medical use thereof
06/20/2012EP2465580A1 Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity
06/20/2012EP2465540A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465539A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465537A1 Microspheres comprising ONO-1301
06/20/2012EP2465535A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465534A1 Methods for treating conditions associated with MASP-2 dependent complement activation
06/20/2012EP2465518A1 Compositions Comprising Lilium Candidum Extracts and Uses Thereof
06/20/2012EP2465516A1 Annatto extract compositions, including geranyl geraniols and methods of use
06/20/2012EP2465513A2 Method and use for increasing efficacy of anti-adhesive compositions in controlling inflammation and pain
06/20/2012EP2465512A1 Pharmaceutical composition for suppressing pain
06/20/2012EP2465511A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465510A2 Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptors and adaptors thereof
06/20/2012EP2465509A1 Oligosaccharide composition for treating acute respiratory tract infections
06/20/2012EP2465508A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
06/20/2012EP2465507A1 Oligosaccharide composition for treating skin diseases
06/20/2012EP2465506A1 Methods and compositions for treating gastrointestinal disorders
06/20/2012EP2465505A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
06/20/2012EP2465504A1 Novel 2,3-diamino-quinazolinone derivatives and their medical use
06/20/2012EP2465503A1 Pharmaceutical solution of cetirizine hydrochloride
06/20/2012EP2465502A1 Compounds useful for treating AIDS
06/20/2012EP2465501A1 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of preparation
06/20/2012EP2465500A1 Therapeutically effective amounts of R(+) and S(-) pramipexole for use in the treatment of parkinson's disease
06/20/2012EP2465499A2 Therapeutic agent for treating pain
1 ... 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 ... 7860